Copyright Reports & Markets. All rights reserved.

Global Point of Care Infectious Disease Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Point of Care Infectious Disease Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Point of Care Infectious Disease Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 HIV POC
    • 1.4.3 Clostridium difficile POC
    • 1.4.4 HBV POC
    • 1.4.5 Pneumonia or Streptococcus associated infections
    • 1.4.6 Respiratory syncytial virus (RSV) POC
    • 1.4.7 HPV POC
    • 1.4.8 Influenza/Flu POC
    • 1.4.9 HCV POC
    • 1.4.10 MRSA POC
    • 1.4.11 TB and drug-resistant TB POC
  • 1.5 Market by Application
    • 1.5.1 Global Point of Care Infectious Disease Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Home
    • 1.5.5 Assisted Living Healthcare Facilities
    • 1.5.6 Laboratories
    • 1.5.7 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Point of Care Infectious Disease Market Perspective (2015-2026)
  • 2.2 Global Point of Care Infectious Disease Growth Trends by Regions
    • 2.2.1 Point of Care Infectious Disease Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Point of Care Infectious Disease Historic Market Share by Regions (2015-2020)
    • 2.2.3 Point of Care Infectious Disease Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Point of Care Infectious Disease Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Point of Care Infectious Disease Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Point of Care Infectious Disease Players by Market Size
    • 3.1.1 Global Top Point of Care Infectious Disease Players by Revenue (2015-2020)
    • 3.1.2 Global Point of Care Infectious Disease Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Point of Care Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Point of Care Infectious Disease Market Concentration Ratio
    • 3.2.1 Global Point of Care Infectious Disease Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Point of Care Infectious Disease Revenue in 2019
  • 3.3 Point of Care Infectious Disease Key Players Head office and Area Served
  • 3.4 Key Players Point of Care Infectious Disease Product Solution and Service
  • 3.5 Date of Enter into Point of Care Infectious Disease Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Point of Care Infectious Disease Historic Market Size by Type (2015-2020)
  • 4.2 Global Point of Care Infectious Disease Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Point of Care Infectious Disease Market Size by Application (2015-2020)
  • 5.2 Global Point of Care Infectious Disease Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Point of Care Infectious Disease Market Size (2015-2020)
  • 6.2 Point of Care Infectious Disease Key Players in North America (2019-2020)
  • 6.3 North America Point of Care Infectious Disease Market Size by Type (2015-2020)
  • 6.4 North America Point of Care Infectious Disease Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Point of Care Infectious Disease Market Size (2015-2020)
  • 7.2 Point of Care Infectious Disease Key Players in Europe (2019-2020)
  • 7.3 Europe Point of Care Infectious Disease Market Size by Type (2015-2020)
  • 7.4 Europe Point of Care Infectious Disease Market Size by Application (2015-2020)

8 China

  • 8.1 China Point of Care Infectious Disease Market Size (2015-2020)
  • 8.2 Point of Care Infectious Disease Key Players in China (2019-2020)
  • 8.3 China Point of Care Infectious Disease Market Size by Type (2015-2020)
  • 8.4 China Point of Care Infectious Disease Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Point of Care Infectious Disease Market Size (2015-2020)
  • 9.2 Point of Care Infectious Disease Key Players in Japan (2019-2020)
  • 9.3 Japan Point of Care Infectious Disease Market Size by Type (2015-2020)
  • 9.4 Japan Point of Care Infectious Disease Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Point of Care Infectious Disease Market Size (2015-2020)
  • 10.2 Point of Care Infectious Disease Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Point of Care Infectious Disease Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Point of Care Infectious Disease Market Size by Application (2015-2020)

11 India

  • 11.1 India Point of Care Infectious Disease Market Size (2015-2020)
  • 11.2 Point of Care Infectious Disease Key Players in India (2019-2020)
  • 11.3 India Point of Care Infectious Disease Market Size by Type (2015-2020)
  • 11.4 India Point of Care Infectious Disease Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Point of Care Infectious Disease Market Size (2015-2020)
  • 12.2 Point of Care Infectious Disease Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Point of Care Infectious Disease Market Size by Type (2015-2020)
  • 12.4 Central & South America Point of Care Infectious Disease Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Siemens Healthineers
    • 13.1.1 Siemens Healthineers Company Details
    • 13.1.2 Siemens Healthineers Business Overview
    • 13.1.3 Siemens Healthineers Point of Care Infectious Disease Introduction
    • 13.1.4 Siemens Healthineers Revenue in Point of Care Infectious Disease Business (2015-2020))
    • 13.1.5 Siemens Healthineers Recent Development
  • 13.2 Trivitron Healthcare
    • 13.2.1 Trivitron Healthcare Company Details
    • 13.2.2 Trivitron Healthcare Business Overview
    • 13.2.3 Trivitron Healthcare Point of Care Infectious Disease Introduction
    • 13.2.4 Trivitron Healthcare Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 13.2.5 Trivitron Healthcare Recent Development
  • 13.3 F. Hoffmann-La Roche Ltd
    • 13.3.1 F. Hoffmann-La Roche Ltd Company Details
    • 13.3.2 F. Hoffmann-La Roche Ltd Business Overview
    • 13.3.3 F. Hoffmann-La Roche Ltd Point of Care Infectious Disease Introduction
    • 13.3.4 F. Hoffmann-La Roche Ltd Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 13.3.5 F. Hoffmann-La Roche Ltd Recent Development
  • 13.4 Abbott
    • 13.4.1 Abbott Company Details
    • 13.4.2 Abbott Business Overview
    • 13.4.3 Abbott Point of Care Infectious Disease Introduction
    • 13.4.4 Abbott Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 13.4.5 Abbott Recent Development
  • 13.5 Quest Diagnostics, Inc
    • 13.5.1 Quest Diagnostics, Inc Company Details
    • 13.5.2 Quest Diagnostics, Inc Business Overview
    • 13.5.3 Quest Diagnostics, Inc Point of Care Infectious Disease Introduction
    • 13.5.4 Quest Diagnostics, Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 13.5.5 Quest Diagnostics, Inc Recent Development
  • 13.6 BD & Company
    • 13.6.1 BD & Company Company Details
    • 13.6.2 BD & Company Business Overview
    • 13.6.3 BD & Company Point of Care Infectious Disease Introduction
    • 13.6.4 BD & Company Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 13.6.5 BD & Company Recent Development
  • 13.7 Chembio Diagnostics Inc
    • 13.7.1 Chembio Diagnostics Inc Company Details
    • 13.7.2 Chembio Diagnostics Inc Business Overview
    • 13.7.3 Chembio Diagnostics Inc Point of Care Infectious Disease Introduction
    • 13.7.4 Chembio Diagnostics Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 13.7.5 Chembio Diagnostics Inc Recent Development
  • 13.8 Trinity Biotech
    • 13.8.1 Trinity Biotech Company Details
    • 13.8.2 Trinity Biotech Business Overview
    • 13.8.3 Trinity Biotech Point of Care Infectious Disease Introduction
    • 13.8.4 Trinity Biotech Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 13.8.5 Trinity Biotech Recent Development
  • 13.9 Cardinal Health
    • 13.9.1 Cardinal Health Company Details
    • 13.9.2 Cardinal Health Business Overview
    • 13.9.3 Cardinal Health Point of Care Infectious Disease Introduction
    • 13.9.4 Cardinal Health Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 13.9.5 Cardinal Health Recent Development
  • 13.10 Bio-Rad Labs Inc.
    • 13.10.1 Bio-Rad Labs Inc. Company Details
    • 13.10.2 Bio-Rad Labs Inc. Business Overview
    • 13.10.3 Bio-Rad Labs Inc. Point of Care Infectious Disease Introduction
    • 13.10.4 Bio-Rad Labs Inc. Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 13.10.5 Bio-Rad Labs Inc. Recent Development
  • 13.11 bioMérieux SA
    • 10.11.1 bioMérieux SA Company Details
    • 10.11.2 bioMérieux SA Business Overview
    • 10.11.3 bioMérieux SA Point of Care Infectious Disease Introduction
    • 10.11.4 bioMérieux SA Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 10.11.5 bioMérieux SA Recent Development
  • 13.12 Thermo Fisher Scientific Inc
    • 10.12.1 Thermo Fisher Scientific Inc Company Details
    • 10.12.2 Thermo Fisher Scientific Inc Business Overview
    • 10.12.3 Thermo Fisher Scientific Inc Point of Care Infectious Disease Introduction
    • 10.12.4 Thermo Fisher Scientific Inc Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 10.12.5 Thermo Fisher Scientific Inc Recent Development
  • 13.13 Sight Diagnostics Ltd.
    • 10.13.1 Sight Diagnostics Ltd. Company Details
    • 10.13.2 Sight Diagnostics Ltd. Business Overview
    • 10.13.3 Sight Diagnostics Ltd. Point of Care Infectious Disease Introduction
    • 10.13.4 Sight Diagnostics Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 10.13.5 Sight Diagnostics Ltd. Recent Development
  • 13.14 Gene POC
    • 10.14.1 Gene POC Company Details
    • 10.14.2 Gene POC Business Overview
    • 10.14.3 Gene POC Point of Care Infectious Disease Introduction
    • 10.14.4 Gene POC Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 10.14.5 Gene POC Recent Development
  • 13.15 Ortho-Clinical Diagnostics
    • 10.15.1 Ortho-Clinical Diagnostics Company Details
    • 10.15.2 Ortho-Clinical Diagnostics Business Overview
    • 10.15.3 Ortho-Clinical Diagnostics Point of Care Infectious Disease Introduction
    • 10.15.4 Ortho-Clinical Diagnostics Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 10.15.5 Ortho-Clinical Diagnostics Recent Development
  • 13.16 OJ-Bio Ltd.
    • 10.16.1 OJ-Bio Ltd. Company Details
    • 10.16.2 OJ-Bio Ltd. Business Overview
    • 10.16.3 OJ-Bio Ltd. Point of Care Infectious Disease Introduction
    • 10.16.4 OJ-Bio Ltd. Revenue in Point of Care Infectious Disease Business (2015-2020)
    • 10.16.5 OJ-Bio Ltd. Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Point of Care Infectious Disease market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Point of Care Infectious Disease market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Siemens Healthineers
    Trivitron Healthcare
    F. Hoffmann-La Roche Ltd
    Abbott
    Quest Diagnostics, Inc
    BD & Company
    Chembio Diagnostics Inc
    Trinity Biotech
    Cardinal Health
    Bio-Rad Labs Inc.
    bioMérieux SA
    Thermo Fisher Scientific Inc
    Sight Diagnostics Ltd.
    Gene POC
    Ortho-Clinical Diagnostics
    OJ-Bio Ltd.

    Market segment by Type, the product can be split into
    HIV POC
    Clostridium difficile POC
    HBV POC
    Pneumonia or Streptococcus associated infections
    Respiratory syncytial virus (RSV) POC
    HPV POC
    Influenza/Flu POC
    HCV POC
    MRSA POC
    TB and drug-resistant TB POC
    Market segment by Application, split into
    Hospitals
    Clinics
    Home
    Assisted Living Healthcare Facilities
    Laboratories
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now